Catalyst Wire Dossier Catalyst Wire Dossier

Atropine 0.05% ophthalmic solution

Atropine
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atropine 0.05% ophthalmic solution, covering 2026-01-23 to 2026-01-23. Get the full timeline:

Most recent: Clinical Trial Update: Myopia Progression Control Using Atropine 0.05% After Pediatric Cataract Surgery And Intraocular Lens Implantation Surgery [NA]

See pricing